Markus Arigoni

Markus Arigoni has a diverse work experience spanning multiple companies and roles. Markus has held various positions at Medartis, starting in 2018 as the Head of Sales for China and Japan, and later transitioning to Head of Global Development Product Management. In 2023, they became the Head of Sales for CMF Japan. Prior to their time at Medartis, Markus served as the CEO of MICRO-MACINAZIONE S.A., which is now a Lonza Company. Markus also worked at DePuy Synthes Companies of Johnson & Johnson, where they held several management roles, including Strategic Account Manager and Business Unit Manager for Spine in China and Switzerland. Before that, they were the Group Manager and Market Development Manager for Biomaterials (Trauma+CMF) at DePuy Synthes. Markus also gained experience at Mathys Australia as a Product Manager and Sales Manager, as well as an International Product Manager for CMF. Markus began their career at Uher AG in Berlin as a Sales Consultant.

Markus Arigoni obtained a Master of Science (MSc) degree in Molecular Biology from the Biozentrum, University of Basel, where they studied from 1993 to 1998. In 2005 to 2007, they pursued a Bachelor of Business Administration (BBA) degree in Business Administration and Management, General at CEIBS Zurich Campus. Currently, from 2021 to 2023, Markus Arigoni is enrolled in the Executive MBA in Digital Transformation program at the University of Applied Sciences of the Grisons.